Safety and Efficacy of Low Molecular Weight Heparin Therapy During Pregnancy: Three Year Experience at a Tertiary Care Center

By Singh Nilanchali   Varshney Priya   Tripathi Reva   Mala Y.   Tyagi Shakun  

The Journal of Obstetrics and Gynecology of India, Vol. 63, Iss. 6, 2013-12 ,pp. : 373-377

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome

By Fouda U. M.   Sayed A. M.   Ramadan D. I.   Fouda I. M.  

Journal of Obstetrics & Gynaecology, Vol. 30, Iss. 8, 2010-11 ,pp. : 842-846

Informa Healthcare

Access to resources Recommend Favorite

The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy

By Eldor A.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 104, Iss. 1, 2002-08 ,pp. : 3-13

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves

By James Andra   Brancazio Leo   Gehrig Thomas   Wang Andrew   Ortel Thomas  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 19, Iss. 9, 2006-09 ,pp. : 543-549

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin (LMWH) in Women with Repeated Implantation Failure

By Allahbadia Gautam  

The Journal of Obstetrics and Gynecology of India, Vol. 62, Iss. 4, 2012-08 ,pp. : 381-383

Springer Publishing Company

Access to resources Recommend Favorite